DE69926480D1 - Acpl dna und polypeptide - Google Patents
Acpl dna und polypeptideInfo
- Publication number
- DE69926480D1 DE69926480D1 DE69926480T DE69926480T DE69926480D1 DE 69926480 D1 DE69926480 D1 DE 69926480D1 DE 69926480 T DE69926480 T DE 69926480T DE 69926480 T DE69926480 T DE 69926480T DE 69926480 D1 DE69926480 D1 DE 69926480D1
- Authority
- DE
- Germany
- Prior art keywords
- polypeptides
- acpl
- acpl dna
- dna
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/417—Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7230198P | 1998-01-23 | 1998-01-23 | |
US72301P | 1998-01-23 | ||
US7883598P | 1998-03-20 | 1998-03-20 | |
US78835P | 1998-03-20 | ||
PCT/US1999/001420 WO1999037773A1 (en) | 1998-01-23 | 1999-01-22 | Acpl dna and polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69926480D1 true DE69926480D1 (de) | 2005-09-08 |
DE69926480T2 DE69926480T2 (de) | 2006-04-13 |
Family
ID=26753223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69926480T Expired - Lifetime DE69926480T2 (de) | 1998-01-23 | 1999-01-22 | Acpl dna und polypeptide |
Country Status (11)
Country | Link |
---|---|
US (7) | US6664077B1 (de) |
EP (1) | EP1049777B1 (de) |
JP (1) | JP4409763B2 (de) |
AT (1) | ATE301195T1 (de) |
AU (1) | AU750767B2 (de) |
CA (1) | CA2318030C (de) |
DE (1) | DE69926480T2 (de) |
ES (1) | ES2245085T3 (de) |
IL (3) | IL137037A0 (de) |
NZ (1) | NZ505499A (de) |
WO (1) | WO1999037773A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326472B1 (en) | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
US20020155526A1 (en) | 1998-09-30 | 2002-10-24 | Busfield Samantha J. | Novel secreted immunomodulatory proteins and uses thereof |
KR101111103B1 (ko) | 2000-02-10 | 2012-02-13 | 아보트 러보러터리즈 | 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법 |
YU103003A (sh) | 2001-06-26 | 2006-05-25 | Abgenix Inc. | Antitela za opgl |
NZ538569A (en) | 2002-09-06 | 2009-02-28 | Amgen Inc | Therapeutic human anti-IL-1R1 monoclonal antibody |
US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
US20050100965A1 (en) | 2003-11-12 | 2005-05-12 | Tariq Ghayur | IL-18 binding proteins |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
PE20070684A1 (es) | 2005-11-14 | 2007-08-06 | Amgen Inc | MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP |
CL2008002153A1 (es) | 2007-07-24 | 2009-06-05 | Amgen Inc | Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r. |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
JP6029581B2 (ja) | 2010-06-19 | 2016-11-24 | メモリアル スローン−ケタリング キャンサー センター | 抗gd2抗体 |
JP6153874B2 (ja) | 2011-02-09 | 2017-06-28 | ナテラ, インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
TWI603198B (zh) * | 2011-05-20 | 2017-10-21 | 英特爾股份有限公司 | 以複數個引擎作資源與互連結構的分散式分配以支援指令序列的執行 |
US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
JP6482525B2 (ja) | 2013-03-15 | 2019-03-13 | メモリアル スローン ケタリング キャンサー センター | 高親和性抗gd2抗体 |
US9708375B2 (en) | 2013-03-15 | 2017-07-18 | Amgen Inc. | Inhibitory polypeptides specific to WNT inhibitors |
US11427627B2 (en) | 2013-09-05 | 2022-08-30 | Amgen Inc. | Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles |
CA2949237C (en) | 2014-05-16 | 2022-08-23 | Amgen Inc. | Assay for detecting th1 and th2 cell populations |
JP6774953B2 (ja) * | 2015-03-24 | 2020-10-28 | ワン メディア,エルエルシー | 高優先通知システムおよび方法 |
EP4428863A2 (de) | 2015-05-11 | 2024-09-11 | Natera, Inc. | Verfahren und zusammensetzungen zur bestimmung der ploidie |
MA47775A (fr) | 2017-03-14 | 2020-01-22 | Amgen Inc | Contrôle des glycoformes afucosylées totales d'anticorps produits en culture cellulaire |
US11773434B2 (en) | 2017-06-20 | 2023-10-03 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free DNA |
US12084720B2 (en) | 2017-12-14 | 2024-09-10 | Natera, Inc. | Assessing graft suitability for transplantation |
IL313983A (en) | 2018-03-26 | 2024-08-01 | Amgen Inc | Fully fucose-free glycoforms of antibodies are produced in cell culture |
CA3090426A1 (en) | 2018-04-14 | 2019-10-17 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
CA3152547A1 (en) | 2019-09-26 | 2021-04-01 | Amgen Inc. | Methods of producing antibody compositions |
WO2021236962A1 (en) | 2020-05-20 | 2021-11-25 | The Medical College Of Wisconsin, Inc. | Compositions and methods for inhibiting cytokine-release syndrome |
US20230273126A1 (en) | 2020-06-04 | 2023-08-31 | Amgen Inc. | Assessment of cleaning procedures of a biotherapeutic manufacturing process |
EP4229080A1 (de) | 2020-10-15 | 2023-08-23 | Amgen Inc. | Relative ungepaarte glycane in antikörperherstellungsverfahren |
AR126089A1 (es) | 2021-06-07 | 2023-09-13 | Amgen Inc | Uso de fucosidasa para controlar el nivel de afucosilación de proteínas glucosiladas |
CA3233279A1 (en) | 2021-10-05 | 2023-04-13 | Amgen Inc. | Fc-gamma receptor ii binding and glycan content |
WO2023215725A1 (en) | 2022-05-02 | 2023-11-09 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2120949T4 (es) * | 1990-06-28 | 2011-12-29 | Sanofi-Aventis Deutschland Gmbh 50% | Proteinas de fusión con porciones de inmunoglobulinas, su preparación y empleo. |
US6326472B1 (en) | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
WO1999019480A2 (en) * | 1997-10-15 | 1999-04-22 | Schering Corporation | Human receptor proteins; related reagents and methods |
-
1999
- 1999-01-22 AT AT99903320T patent/ATE301195T1/de active
- 1999-01-22 JP JP2000528680A patent/JP4409763B2/ja not_active Expired - Fee Related
- 1999-01-22 ES ES99903320T patent/ES2245085T3/es not_active Expired - Lifetime
- 1999-01-22 AU AU23373/99A patent/AU750767B2/en not_active Ceased
- 1999-01-22 WO PCT/US1999/001420 patent/WO1999037773A1/en active Application Filing
- 1999-01-22 DE DE69926480T patent/DE69926480T2/de not_active Expired - Lifetime
- 1999-01-22 EP EP99903320A patent/EP1049777B1/de not_active Expired - Lifetime
- 1999-01-22 NZ NZ505499A patent/NZ505499A/en not_active IP Right Cessation
- 1999-01-22 IL IL13703799A patent/IL137037A0/xx unknown
- 1999-01-22 CA CA002318030A patent/CA2318030C/en not_active Expired - Fee Related
-
2000
- 2000-06-27 IL IL137037A patent/IL137037A/en not_active IP Right Cessation
- 2000-07-14 US US09/616,530 patent/US6664077B1/en not_active Expired - Fee Related
-
2002
- 2002-08-02 US US10/212,356 patent/US6692740B2/en not_active Expired - Fee Related
- 2002-08-02 US US10/212,287 patent/US6693171B2/en not_active Expired - Fee Related
-
2003
- 2003-12-15 US US10/737,146 patent/US20040248254A1/en not_active Abandoned
-
2004
- 2004-02-06 US US10/774,192 patent/US7270817B2/en not_active Expired - Fee Related
-
2007
- 2007-09-17 US US11/901,595 patent/US7838248B2/en not_active Expired - Fee Related
-
2010
- 2010-10-12 US US12/903,008 patent/US7993845B2/en not_active Expired - Fee Related
-
2011
- 2011-04-05 IL IL212140A patent/IL212140A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2245085T3 (es) | 2005-12-16 |
US20030100062A1 (en) | 2003-05-29 |
US20030003542A1 (en) | 2003-01-02 |
NZ505499A (en) | 2002-07-26 |
IL137037A0 (en) | 2001-06-14 |
EP1049777A1 (de) | 2000-11-08 |
US20040138421A1 (en) | 2004-07-15 |
WO1999037773A1 (en) | 1999-07-29 |
US20090004674A1 (en) | 2009-01-01 |
AU2337399A (en) | 1999-08-09 |
US20040248254A1 (en) | 2004-12-09 |
IL137037A (en) | 2011-05-31 |
US6692740B2 (en) | 2004-02-17 |
US6664077B1 (en) | 2003-12-16 |
IL212140A (en) | 2013-05-30 |
EP1049777B1 (de) | 2005-08-03 |
AU750767B2 (en) | 2002-07-25 |
CA2318030A1 (en) | 1999-07-29 |
US7993845B2 (en) | 2011-08-09 |
US7838248B2 (en) | 2010-11-23 |
US7270817B2 (en) | 2007-09-18 |
CA2318030C (en) | 2009-02-17 |
DE69926480T2 (de) | 2006-04-13 |
US20110027805A1 (en) | 2011-02-03 |
JP2002500887A (ja) | 2002-01-15 |
IL212140A0 (en) | 2011-06-30 |
ATE301195T1 (de) | 2005-08-15 |
JP4409763B2 (ja) | 2010-02-03 |
US6693171B2 (en) | 2004-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69926480D1 (de) | Acpl dna und polypeptide | |
DE69936105D1 (de) | Menschliche tslp nukleinsäuren und polypeptide | |
ATE305510T1 (de) | Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden | |
CY1107594T1 (el) | DNA ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ IL-1η | |
ATE534742T1 (de) | Polypeptide und nukleinsäuren von phorphorymonas gingivalis | |
FI930626A (fi) | Proteinstruktur hos vaexttoxingelonin | |
WO1999041388A3 (en) | Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides | |
CY1105405T1 (el) | Dna και πολυπεπτιδια il-1ζ, παραλλαγων ματισματος il-1ζ και xrec2 | |
CY1105226T1 (el) | Dna και πολυπεπτιδια il-1 εψιλον ανθρωπου | |
WO2000008180A3 (en) | HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS | |
WO2001055211A3 (en) | Fil-1 theta dnas and polypeptides | |
WO1999031256A3 (en) | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis | |
WO2000008177A3 (en) | Death associated kinase containing ankyrin repeats (dakar) | |
WO2000043525A3 (en) | Metalloproteinase-disintegrin family members: svph dnas and polypeptides | |
DE60124380D1 (de) | Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure | |
WO2000008178A3 (en) | Murine dna molecules encoding polypeptides having kinase functions | |
DK1078072T3 (da) | Nye peptidfragmenter til oprensning af proteiner | |
EP1690871A3 (de) | Xrec2 DNS und Polypeptide | |
NZ505866A (en) | V196 (also known as RAMP2) DNA and polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN |